U.S. Food and Drug Administration Building
Great Room, White Oak Campus
10903 New Hampshire Avenue Silver Spring, MD 20903
The 2024 BioCompute conference and workshop, hosted by the GW HIVE (High-Performance Integrated Virtual Environment) Lab in collaboration with the U.S. Food and Drug Administration, offers an opportunity to learn about interoperability between platforms that host BioCompute Objects (BCOs), the FDA’s “Portal” for reading, writing, and sharing BCOs, real world applications including intended use in regulatory submissions, and potential implementations, including the use of AI/ML. The conference will feature perspectives from both FDA and industry around the use of BioCompute in regulatory submissions, challenges for implementation, and tools designed to work with the standard. Join us for an in-depth discussion of BCO standards and an opportunity to view other projects during our poster session.
Plenary Speaker: Peter Marks, MD, PhD, center director, of the FDA Center for Biologics Evaluation and Research.
Workshop Topics:
- Updates on BioCompute since the last workshop
- Need for BCO from the perspective of the FDA
- BCODB and Portal's use at the FDA
- Adoption and usage of BCO in a regulatory context
- Technical and administrative updates
- BCO platform interoperability
- Exemplar workflows and real-world applications
- BCO-Nextflow
- Potential AI/ML-related implementations
- BCO-related Q&A and roundtable discussion
Learn more about the BioCompute Project.
Visit the GW HIVE Lab website for more information about the lab.